Inventor
FENG LICHUN
CN34 patents
⚠️ This page may combine multiple inventors who share the name “FENG LICHUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE PALO ALTO LLC
11 patentsUS7595405B2Sep 29, 2009
Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC7 citations74
US8048905B2Nov 1, 2011
Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC4 citations63
US7786110B2Aug 31, 2010
Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC5 citations63
US10201525B2Feb 12, 2019
Tetrazole-substituted arylamides as PX2 and PX2/3 antagonists
ROCHE PALO ALTO LLC0 citations52
US9896439B2Feb 20, 2018
Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC0 citations52
US9849136B2Dec 26, 2017
Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC0 citations52
US9617254B2Apr 11, 2017
Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC0 citations52
US9512089B2Dec 6, 2016
Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC0 citations52
US9512112B2Dec 6, 2016
Substituted pyridines as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC0 citations52
US7989637B2Aug 2, 2011
Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC0 citations52
US7858654B2Dec 28, 2010
Imidazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC0 citations42
CHEN LI
11 patentsUS8841336B2Sep 23, 2014
Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
CHEN LI4 citations73
US8871756B2Oct 28, 2014
Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
CHEN LI4 citations72
US8119644B2Feb 21, 2012
Thiadiazole-substituted arylamides as P2X3 and P2X2/3 antagonists
CHEN LI3 citations62
US9173861B2Nov 3, 2015
Thiadiazole-substituted arylamides as P2X3 and P2X2/3 antagonists
CHEN LI1 citations52
US8809402B2Aug 19, 2014
Oxazolone and pyrrolidinone-substituted biphenyls as P2X3 and P2X2/3 antagonists
CHEN LI0 citations52
US8501933B2Aug 6, 2013
Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists
CHEN LI1 citations52
US8440708B2May 14, 2013
Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists
CHEN LI1 citations52
US8440673B2May 14, 2013
Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
CHEN LI0 citations52
US8093275B2Jan 10, 2012
Oxazolone and pyrrolidinone-substituted pryidine amides as P2X3 and P2X2/3 antagonists
CHEN LI0 citations52
US8592594B2Nov 26, 2013
Tetrahydro-quinoline derivatives
CHEN LI1 citations51
US8258149B2Sep 4, 2012
Isoquinoline derivatives
CHEN LI0 citations40
HOFFMANN LA ROCHE
5 patentsUSRE49481EApr 4, 2023
Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
HOFFMANN LA ROCHE0 citations62
US8354443B2Jan 15, 2013
Cyclopropane indolinone derivatives
HOFFMANN LA ROCHE2 citations62
US8344137B2Jan 1, 2013
3,3-dimethyl tetrahydroquinoline derivatives
HOFFMANN LA ROCHE2 citations61
US8778973B2Jul 15, 2014
Alkene oxindole derivatives
HOFFMANN LA ROCHE2 citations60
US8586747B2Nov 19, 2013
3,3-dimethyl tetrahydroquinoline derivatives
HOFFMANN LA ROCHE1 citations51